Renovaro Biosciences (RENB) Total Expenses

Annual Total Expenses

$27.39 M
+$7.79 M+39.76%

30 June 2024

RENB Total Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Expenses

$5.72 M
+$259.50 K+4.75%

30 September 2024

RENB Quarterly Total Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RENB Total Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+39.8%-35.6%
3 y3 years+17.0%-9.6%
5 y5 years+149.2%+103.1%

RENB Total Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+39.8%-35.6%+44.0%
5 y5 yearsat high+149.2%-59.6%+103.1%
alltimeall timeat high>+9999.0%-59.6%

Renovaro Biosciences Total Expenses History

DateAnnualQuarterly
Sept 2024
-
$5.72 M(+4.7%)
June 2024
$27.39 M(+39.8%)
$5.46 M(-37.7%)
Mar 2024
-
$8.77 M(+105.4%)
Dec 2023
-
$4.27 M(-51.9%)
Sept 2023
-
$8.88 M(+123.5%)
June 2023
$19.60 M(-14.1%)
-
June 2023
-
$3.98 M(-2.2%)
Mar 2023
-
$4.06 M(-7.0%)
Dec 2022
-
$4.37 M(-39.3%)
Sept 2022
-
$7.19 M(+45.1%)
June 2022
$22.83 M(-2.5%)
$4.96 M(+22.8%)
Mar 2022
-
$4.03 M(-36.3%)
Dec 2021
-
$6.33 M(-15.6%)
Sept 2021
-
$7.50 M(-47.1%)
June 2021
$23.40 M(+96.3%)
$14.18 M(+364.5%)
Mar 2021
-
$3.05 M(-7.6%)
Dec 2020
-
$3.31 M(+15.6%)
Sept 2020
-
$2.86 M(+0.9%)
June 2020
$11.92 M(+8.5%)
$2.83 M(-26.0%)
Mar 2020
-
$3.83 M(+35.9%)
Dec 2019
-
$2.82 M(+15.4%)
Sept 2019
-
$2.44 M(+15.8%)
June 2019
$10.99 M(+106.2%)
$2.11 M(-21.4%)
Mar 2019
-
$2.69 M(-38.7%)
Dec 2018
-
$4.38 M(+141.7%)
Sept 2018
-
$1.81 M(+888.5%)
June 2018
$5.33 M
$183.40 K(-94.3%)
DateAnnualQuarterly
Mar 2018
-
$3.24 M(+152.8%)
Dec 2017
-
$1.28 M(+104.7%)
Sept 2017
-
$625.80 K(-3.5%)
June 2017
$2.40 M(+10.9%)
$648.30 K(+84.7%)
Mar 2017
-
$351.00 K(-36.0%)
Dec 2016
-
$548.80 K(-35.6%)
Sept 2016
-
$852.30 K(+27.0%)
June 2016
$2.16 M(-20.9%)
$671.20 K(+30.7%)
Mar 2016
-
$513.60 K(-19.4%)
Dec 2015
-
$637.50 K(+86.7%)
Sept 2015
-
$341.40 K(-60.6%)
June 2015
$2.73 M(+12.6%)
-
Mar 2015
-
$865.50 K(-7.5%)
Dec 2014
$2.43 M(+6447.7%)
$935.30 K(+82.1%)
Sept 2014
-
$513.70 K(-9.6%)
June 2014
-
$568.10 K(+37.9%)
Mar 2014
-
$412.10 K(+4987.7%)
Dec 2013
-
$8100.00(-49.4%)
Sept 2013
-
$16.00 K(+540.0%)
June 2013
-
$2500.00(-73.4%)
Mar 2013
$37.10 K(+24.1%)
$9400.00(-2.1%)
Dec 2012
-
$9600.00(+37.1%)
Sept 2012
-
$7000.00(-36.4%)
June 2012
-
$11.00 K(+150.0%)
Mar 2012
$29.90 K(-12.8%)
$4400.00(-61.4%)
Dec 2011
$34.30 K
$11.40 K(-19.7%)
Sept 2011
-
$14.20 K(>+9900.0%)
June 2011
-
$0.00

FAQ

  • What is Renovaro Biosciences annual total expenses?
  • What is the all time high annual total expenses for Renovaro Biosciences?
  • What is Renovaro Biosciences annual total expenses year-on-year change?
  • What is Renovaro Biosciences quarterly total expenses?
  • What is the all time high quarterly total expenses for Renovaro Biosciences?
  • What is Renovaro Biosciences quarterly total expenses year-on-year change?

What is Renovaro Biosciences annual total expenses?

The current annual total expenses of RENB is $27.39 M

What is the all time high annual total expenses for Renovaro Biosciences?

Renovaro Biosciences all-time high annual total expenses is $27.39 M

What is Renovaro Biosciences annual total expenses year-on-year change?

Over the past year, RENB annual total expenses has changed by +$7.79 M (+39.76%)

What is Renovaro Biosciences quarterly total expenses?

The current quarterly total expenses of RENB is $5.72 M

What is the all time high quarterly total expenses for Renovaro Biosciences?

Renovaro Biosciences all-time high quarterly total expenses is $14.18 M

What is Renovaro Biosciences quarterly total expenses year-on-year change?

Over the past year, RENB quarterly total expenses has changed by -$3.16 M (-35.57%)